These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27937049)

  • 1. Agglomeration of celecoxib by quasi-emulsion solvent diffusion method without stabilizer: effect of good solvent.
    Maghsoodi M; Nokhodchi A
    Pharm Dev Technol; 2018 Dec; 23(10):1037-1046. PubMed ID: 27937049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.
    Maghsoodi M; Nokhodchi A
    Adv Pharm Bull; 2016 Dec; 6(4):607-616. PubMed ID: 28101468
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards a better understanding of the role of stabilizers in QESD crystallizations.
    Hansen J; Kleinebudde P
    Pharm Res; 2022 Dec; 39(12):3123-3136. PubMed ID: 35266086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
    Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of binder liquid type on spherical crystallization.
    Maghsoodi M; Hajipour A
    Drug Dev Ind Pharm; 2014 Nov; 40(11):1468-75. PubMed ID: 23937581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
    Dalvadi H; Parmar K; Yadav S
    Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.
    Hansen J; Kleinebudde P
    Eur J Pharm Biopharm; 2021 Feb; 159():170-176. PubMed ID: 33460735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved processability of ethambutol hydrochloride by spherical agglomeration.
    Nitsure A; Patel D; Wairkar S
    Pharm Dev Technol; 2020 Mar; 25(3):376-384. PubMed ID: 31842656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
    Patil SV; Pawar AP; Sahoo SK
    Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
    Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
    Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing flowability of lamivudine through quasi-emulsion solvent-diffusion (QESD) crystallization: A comprehensive study on surfactant impact, particle morphology by QbD concepts and tablet compression challenges.
    Sreeharsha N; Gajula LR; S SK; Bhavani PD; Goudanavar P; A R; Naveen NR; Shiroorkar PN; Meravanige G; Telsang M; Asif AH; Sreenivasalu PKP
    Eur J Pharm Sci; 2024 Sep; 200():106835. PubMed ID: 38908413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of solvent in differential phase behavior of celecoxib during spray drying.
    Thakore SD; Prasad R; Dalvi SV; Bansal AK
    Int J Pharm; 2020 Jul; 585():119489. PubMed ID: 32522504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.
    Chen H; Wang C; Kang H; Zhi B; Haynes CL; Aburub A; Sun CC
    Int J Pharm; 2020 Jan; 574():118914. PubMed ID: 31811924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method.
    Nocent M; Bertocchi L; Espitalier F; Baron M; Couarraze G
    J Pharm Sci; 2001 Oct; 90(10):1620-7. PubMed ID: 11745720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres.
    Quintanar-Guerrero D; Tamayo-Esquivel D; Ganem-Quintanar A; Allémann E; Doelker E
    Eur J Pharm Sci; 2005 Oct; 26(2):211-8. PubMed ID: 16046105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved compression properties of propyphenazone spherical crystals.
    Di Martino P; Di Cristofaro R; Barthélémy C; Joiris E; Palmieri Filippo G; Sante M
    Int J Pharm; 2000 Mar; 197(1-2):95-106. PubMed ID: 10704797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of some additives on the efficiency of binder liquid in wet agglomeration of crystals.
    Maghsoodi M; Nabizadeh H; Nokhodchi A
    Pharm Dev Technol; 2017 Sep; 22(6):827-835. PubMed ID: 27387408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design.
    Gaikwad VL; Jadhav NR; Pawar AP; Mahadik KR
    AAPS PharmSciTech; 2019 May; 20(5):192. PubMed ID: 31115715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.